StockData
Valion Bio, Inc. logo

Valion Bio, Inc. (VBIO) income statement

VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.50−0.04 (-7.55%)

Close on Nov 18, 2026Market cap $2.09MP/E –Yield –

See a number that looks wrong?